Abbott Laboratories (ABL.DE)
-XETRA Ticker: 824100/ISIN: US0028241000 28.41 
0.71(2.55%) 15 May 12:30
| Prev Close: | 28.41 |
|---|
| Open: | 28.41 |
|---|
| Bid: | 28.58 |
|---|
| Ask: | 29.31 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 28.41 - 28.41 |
|---|
| 52wk Range: | 28.41 - 38.46 |
|---|
| Volume: | 45 |
|---|
| Avg Vol (3m): | N/A |
|---|
| Market Cap: | 44.28b |
|---|
| P/E (ttm): | 8.66 |
|---|
| EPS (ttm): | 3.28 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.11 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine ins...
more 